Beverage News: Green Mountain Coffee Roasters Inc. (GMCR)’s Accounting Standards, Starbucks Corporation (SBUX)’s Legal Battle & Sodastream International Ltd (SODA)

Can the Recent Uptrend Continue for Green Mountain Coffee Roasters Inc. (GMCR)? (Nasdaq)
Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) has been on the move lately as the stock has risen by 12.3% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue? While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on GMCR is moving in the right direction…

Starbucks Corp. Director Sells $1,400,133.84 in Stock (SBUX) (WatchListNews)
Starbucks Corporation (NASDAQ:SBUX) Director James Shennan, Jr. sold 19,698 shares of Starbucks Corp. stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $71.08, for a total transaction of $1,400,133.84. Following the sale, the director now directly owns 10,402 shares of the company’s stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. A number of research firms have recently commented on SBUX. Analysts at Ned Davis Research upgraded shares of Starbucks Corp.

Starbucks to get more Colombians drinking coffee, rival hopes (BRecorder)
The Juan Valdez cafe chain, owned by farmers and beloved by Colombians, expects the imminent arrival of Starbucks Corporation (NASDAQ:SBUX) to help it boost surprisingly low consumption of the beverage in a nation that grows much of the world’s tastiest arabica. The Seattle-based coffee chain will open about 50 stores serving Colombian-only coffee in the Andean country in five years starting in 2014, it announced this week. The company is already the single-biggest exporter of coffee from Colombia.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!